98 related articles for article (PubMed ID: 16092668)
1. Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients.
Surowiak P; Materna V; Kłak K; Spaczyński M; Dietel M; Kristiansen G; Lage H; Zabel M
Pol J Pathol; 2005; 56(2):69-74. PubMed ID: 16092668
[TBL] [Abstract][Full Text] [Related]
2. CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases.
Surowiak P; Materna V; Paluchowski P; Matkowski R; Wojnar A; Maciejczyk A; Pudelko M; Kornafel J; Dietel M; Kristiansen G; Lage H; Zabel M
Anticancer Res; 2006; 26(1B):629-34. PubMed ID: 16739331
[TBL] [Abstract][Full Text] [Related]
3. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
[TBL] [Abstract][Full Text] [Related]
4. The expression of metallothionein (MT) and proliferation intensity in ovarian cancers treated with cisplatin and paclitaxel.
Surowiak P; Kaplenko I; Spaczyński M; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):493-5. PubMed ID: 14655150
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors.
Choi YL; Kim SH; Shin YK; Hong YC; Lee SJ; Kang SY; Ahn G
Gynecol Oncol; 2005 May; 97(2):379-86. PubMed ID: 15863133
[TBL] [Abstract][Full Text] [Related]
6. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival.
Weichert W; Denkert C; Burkhardt M; Gansukh T; Bellach J; Altevogt P; Dietel M; Kristiansen G
Clin Cancer Res; 2005 Sep; 11(18):6574-81. PubMed ID: 16166435
[TBL] [Abstract][Full Text] [Related]
8. CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients.
Surowiak P; Materna V; Maciejczyk A; Kaplenko I; Spaczynski M; Dietel M; Lage H; Zabel M
Anticancer Res; 2006; 26(6C):4943-8. PubMed ID: 17214367
[TBL] [Abstract][Full Text] [Related]
9. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.
Kristiansen G; Denkert C; Schlüns K; Dahl E; Pilarsky C; Hauptmann S
Am J Pathol; 2002 Oct; 161(4):1215-21. PubMed ID: 12368195
[TBL] [Abstract][Full Text] [Related]
10. CD24 expression is a new prognostic marker in breast cancer.
Kristiansen G; Winzer KJ; Mayordomo E; Bellach J; Schlüns K; Denkert C; Dahl E; Pilarsky C; Altevogt P; Guski H; Dietel M
Clin Cancer Res; 2003 Oct; 9(13):4906-13. PubMed ID: 14581365
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance.
Lee HJ; Kim DI; Kwak C; Ku JH; Moon KC
Urology; 2008 Sep; 72(3):603-7. PubMed ID: 18384848
[TBL] [Abstract][Full Text] [Related]
13. Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates.
Surowiak P; Materna V; Drag-Zalesinska M; Wojnar A; Kaplenko I; Spaczyński M; Dietel M; Zabel M; Lage H
Int J Gynecol Pathol; 2006 Apr; 25(2):131-9. PubMed ID: 16633061
[TBL] [Abstract][Full Text] [Related]
14. Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue.
Surowiak P; Materna V; Kaplenko I; Spaczyński M; Dietel M; Kristiansen G; Lage H; Zabel M
Int J Gynecol Cancer; 2006; 16(2):515-21. PubMed ID: 16681720
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
Abraham BK; Fritz P; McClellan M; Hauptvogel P; Athelogou M; Brauch H
Clin Cancer Res; 2005 Feb; 11(3):1154-9. PubMed ID: 15709183
[TBL] [Abstract][Full Text] [Related]
16. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
18. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
Kwon GY; Ha H; Ahn G; Park SY; Huh SJ; Park W
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1150-6. PubMed ID: 17692475
[TBL] [Abstract][Full Text] [Related]
19. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
Dowsett M; Smith IE; Ebbs SR; Dixon JM; Skene A; A'Hern R; Salter J; Detre S; Hills M; Walsh G;
J Natl Cancer Inst; 2007 Jan; 99(2):167-70. PubMed ID: 17228000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
